G&E Herbal Biotechnology Co., Ltd.
G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products in Taiwan. It offers Hepanamin capsules; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as adult products, in… Read more
G&E Herbal Biotechnology Co., Ltd. (4911) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.004x
Based on the latest financial reports, G&E Herbal Biotechnology Co., Ltd. (4911) has a cash flow conversion efficiency ratio of 0.004x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$3.68 Million) by net assets (NT$900.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
G&E Herbal Biotechnology Co., Ltd. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how G&E Herbal Biotechnology Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
G&E Herbal Biotechnology Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of G&E Herbal Biotechnology Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
QUALITAS SEMICONDUCTOR CO. LTD.
KQ:432720
|
-0.056x |
|
Helios Fairfax Partners Corporation
PINK:FFXXF
|
0.014x |
|
PCC Rokita SA
WAR:PCR
|
0.065x |
|
Clarke Inc
PINK:CLKFF
|
0.044x |
|
Mobiletron Electronics Co Ltd
TW:1533
|
0.018x |
|
Daaz Bara Lestari Tbk
JK:DAAZ
|
0.306x |
|
BABYTREE GROUP
F:BTR
|
N/A |
|
Nitratos de Chile SA
SN:NITRATOS
|
0.085x |
Annual Cash Flow Conversion Efficiency for G&E Herbal Biotechnology Co., Ltd. (2021–2024)
The table below shows the annual cash flow conversion efficiency of G&E Herbal Biotechnology Co., Ltd. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$833.53 Million | NT$134.68 Million | 0.162x | +8.67% |
| 2023-12-31 | NT$763.24 Million | NT$113.48 Million | 0.149x | +2.76% |
| 2022-12-31 | NT$690.84 Million | NT$99.96 Million | 0.145x | +1176.00% |
| 2021-12-31 | NT$683.45 Million | NT$-9.19 Million | -0.013x | -- |